Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
Fiche publication
Date publication
avril 2021
Journal
Clinics and research in hepatology and gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Mme POZET Astrid
Tous les auteurs :
Lapeyre-Prost A, Perkins G, Vallee M, Pozet A, Tougeron D, Maillet M, Locher C, Dreanic J, Legoux JL, Lièvre A, Lecaille C, Sabate JM, Mary F, Bonnetain F, Jaulmes-Bouillot H, Behal F, Landi B, Taieb J
Lien Pubmed
Résumé
The use of chemotherapy (CT) near the end-of-life (EOL) is an important issue in oncology since it could degrade quality of life. CT near EOL is still poorly studied, with no dedicated study in gastrointestinal (GI) cancer patients.
Mots clés
End-of-life chemotherapy, aggressiveness of end-of-life care, digestive oncology, palliative care, palliative care team
Référence
Clin Res Hepatol Gastroenterol. 2021 Apr 27;:101709